| （単位：千ドル） | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 52,845 | 63,461 | 79,490 | 95,517 | 155,972 | 314,819 | 157,607 | 187,584 |
| 営業費用 | 67,637 | 77,782 | 94,011 | 110,547 | 183,240 | 333,772 | 178,168 | 221,561 |
| 営業利益 | -67,637 | -77,782 | -94,011 | -110,547 | -183,240 | -333,772 | -178,168 | -221,561 |
| 経常（税引前）利益 | -67,637 | -69,553 | -88,169 | -105,861 | -178,935 | -319,594 | -160,363 | -221,068 |
| 法人税等合計 | 1,216 | 939 | 2,177 | -3,287 | 569 | 177 | -59 | 609 |
| 実効税率（％） | ||||||||
| 純利益 | -68,853 | -70,492 | -90,346 | -102,574 | -179,504 | -319,771 | -160,304 | -221,677 |
| 一株あたり利益 | -1.75 | -1.03 | -1.32 | -1.5 | -2.2 | -3.64 | -1.7 | -2.17 |
| 希薄化後一株あたり利益 | -1.75 | -1.03 | -1.32 | -1.5 | -2.2 | -3.64 | -1.7 | -2.17 |
| EBITDA | - | - | - | - | - |